Inhibin A as a tumor marker for primary bilateral macronodular adrenal hyperplasia.
Rachel WurthCrystal KamilarisNaris NilubolSamira M SadowskiAnnabel BerthonMartha M QuezadoFabio R FauczConstantine A StratakisFady Hannah-ShmouniPublished in: Endocrinology, diabetes & metabolism case reports (2020)
PBMAH is a rare cause of CS. PBMAH may have an insidious presentation, allowing the disease to progress for years prior to diagnosis. Inhibin A is a heterodimeric glycoprotein hormone expressed in the gonads and adrenal cortex. Inhibin A serum concentrations are elevated in some patients with PBMAH, suggesting the potential use of this hormone as a tumor marker. Further exploration of serum inhibin A concentration, as it relates to PBMAH disease progression, is warranted to determine if this hormone could serve as an early detection marker and/or predictor of successful surgical treatment.